FRESENIUS SE&CO KGAAFF

FRESENIUS SE&CO KGAA

791.93MXND
0.000.00%
Last update at Mar 19, 20:06 GMT
MXN
No trades
See on Supercharts

FRE/N fundamentals

Key facts

Market capitalization‪482.94 B‬MXN
Founded2011
CEOMichael Sen
About

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Ownership
‪‪563.24 M‬‬
Free Float shares
‪‪411.09 M‬‬ (72.99%)
Closely held shares
‪‪152.15 M‬‬ (27.01%)
Free Float shares
‪‪411.09 M‬‬ (72.99%)
Closely held shares
‪‪152.15 M‬‬ (27.01%)
Capital structure
Market cap
‪‪482.94 B‬‬
Enterprise value
‪‪482.94 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪482.94 B‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−6%‬
‪−3%‬
‪0%‬
‪3%‬
‪6%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−45.00 B‬‬
‪0.00‬
‪‪45.00 B‬‬
‪‪90.00 B‬‬
‪‪135.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪35.00 B‬‬
‪‪70.00 B‬‬
‪‪105.00 B‬‬
‪‪140.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪35.00 B‬‬
‪‪70.00 B‬‬
‪‪105.00 B‬‬
‪‪140.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Fresenius Helios
Fresenius Kabi
Fresenius Vamed
By country
Period: 2024
Germany
Spain
Europe
North America
Asia Pacific
Latin America
Africa

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪30.00 B‬‬
‪‪60.00 B‬‬
‪‪90.00 B‬‬
‪‪120.00 B‬‬
Actual
Estimate
Earnings
Next:May 7, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪4.50‬
‪9.00‬
‪13.50‬
‪18.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
126.57%
Payout ratio (TTM)
Dividend yield TTM
0.00%
Last payment
Last ex-date
Dividend history
‪0.0%‬
‪0.9%‬
‪1.8%‬
‪2.7%‬
‪3.6%‬
2020
2021
2022
2023
2024
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−100.00 B‬‬
‪0.00‬
‪‪100.00 B‬‬
‪‪200.00 B‬‬
‪‪300.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.